Lijuan Song | Cellular Neuroscience | Best Researcher Award

Published on 26/04/2025 by Neuroscientists

Prof. Lijuan Song | Cellular Neuroscience | Best Researcher Award

Prof. Lijuan Song, Shanxi University of Chinese Medicine, China.

Throughout my career, I have passionately committed myself to integrating traditional Chinese medicine and Western medicine to advance the prevention and treatment of brain diseases, particularly ischemic cerebrovascular diseases and neurodegenerative disorders. By leading 14 national and provincial-level research projects, publishing over 130 academic papers, and contributing significantly to educational reform, I have built a strong foundation of scientific innovation and clinical excellence. With achievements recognized both nationally and internationally, and a consistent focus on combining research, teaching, and clinical work, I have significantly impacted the fields of neuroprotection and integrative medicine.

Profile

Scopus

🎓 Early Academic Pursuits

From the outset of my academic journey, I committed myself to the profound study of both traditional Chinese medicine and Western medicine, aspiring to bridge these two disciplines for the betterment of brain disease treatment. I pursued a rigorous path of education and research, laying a strong foundation that later allowed me to integrate diverse medical perspectives. Early in my career, I developed a particular interest in ischemic cerebrovascular diseases and neurodegenerative conditions, setting the stage for my lifelong mission to innovate in these critical areas.

🩺 Professional Endeavors

My professional career has been a dynamic blend of teaching, clinical practice, and scientific research, with a special focus on the prevention and treatment of brain diseases. I have successfully presided over 14 prestigious national and provincial-level projects, including those funded by the National Natural Science Foundation of China and the China Postdoctoral Science Foundation. Through my work, I have consistently emphasized the value of integrating traditional Chinese medicine with modern Western practices, ensuring that my clinical and research contributions are both culturally rooted and globally relevant.

🔬 Contributions and Research Focus

Throughout my research journey, I have concentrated on ischemic cerebrovascular diseases and neurodegenerative diseases, pioneering integrated approaches for their prevention and treatment. I have published 133 scientific papers, including 45 in SCI-indexed journals, with nearly 700 citations and an H-index of 15. One of my papers published in Neural Regeneration Research (NRR) has been recognized in the ESI highest citation list, achieving an impressive 97 citations. Beyond scientific research, I have also contributed significantly to educational innovation, authoring educational reform articles in the China Journal of Traditional Chinese Medicine and editing influential academic books.

🏆 Accolades and Recognition

My dedication to scientific advancement and education has earned me multiple prestigious honors. As the first author, I received the First Prize of the Academic Achievement Award from the China Association for the Promotion of Traditional Chinese Medicine Research. I have secured three authorized patents and two software copyrights, further showcasing my commitment to innovation. Additionally, my work has been featured through oral presentations at internationally renowned academic forums such as the Autoimmunity Congress and the World Stroke Congress, and recognized by respected platforms like Logic Neuroscience and Neuroweekly.

🌍 Impact and Influence

My influence extends beyond academia into public science education and medical philosophy dialogues. I have been repeatedly invited to deliver popular science talks and academic lectures at events like the Medical Philosophy Expert Meeting Room. My presentation at the 2022 International Neural Regeneration Summit Forum earned the Most Popular Award, affirming my ability to translate complex research into impactful and accessible knowledge for diverse audiences.

📚 Legacy in Education and Publishing

In addition to research and clinical achievements, I have made significant contributions to academic publishing and educational reform. My independently authored book, Progress in Integrated Traditional Chinese and Western Medicine Prevention and Treatment of Ischemic Cerebrovascular Disease, was published by People’s Health Publishing House. I have served as the first editor-in-chief for three important books, including Exploration of Teaching Models in Higher Education Pharmaceutical Education, which was honored by its selection into the “Library of Young Scholars in Universities,” marking a lasting contribution to the future of pharmaceutical education.

🚀 Future Contributions and Aspirations

Looking ahead, I aspire to further deepen the integration of traditional Chinese and Western medicine, particularly in brain disease prevention and therapy. I am committed to leading new research directions, fostering international collaborations, and nurturing a new generation of scholars who value the richness of cross-cultural medical practices. My future endeavors will continue to reflect a relentless pursuit of scientific excellence, compassionate clinical practice, and transformative education for the global health community.

Publication

Title: Effect of tetramethylpyrazine on neuroinflammation after cerebral ischemia and hypoxia based on mannose-binding lectin
Authors: Y. Duan, Yanzhe; J. Hua, Jianlin; Y. Yan, Yuqing; L. Song, Lijuan
Year: 2025

Title: Polysaccharides from Ganoderma lucidum attenuate cognitive impairment in 5xFAD mice by inhibiting oxidative stress and modulating mitochondrial dynamics via the Nrf2/antioxidative axis activation
Authors: J. Yu, Jiezhong; C. Ma, Cungen
Year: 2025

Title: Hydroxysafflower yellow A alleviates the inflammatory response in astrocytes following cerebral ischemia by inhibiting the LCN2/STAT3 feedback loop
Authors: L. Song, Lijuan; Y. Wu, Yige; L. Yin, Lijun; B. Xiao, Baoguo; C. Ma, Cungen
Year: 2025

Title: Mechanism of senegenin in improving lipopolysacchride-induced inflammatory response of BV2 microglial cell
Authors: B. Mu, Bingtao; M. Guo, Minfang; J. Yu, Jingwen; J. Yu, Jiezhong; L. Song, Lijuan
Year: 2025

Title: Effectiveness and Safety of Blending Traditional Chinese Medicine With Western Medicine for Enhanced Secondary Stroke Prevention: A Meta-analysis of RCTs
Authors: C. Wen, Chunli; L. Song, Lijuan; C. Ma, Cungen; F. Hu, Fengyun; L. Zhu, Linggqun
Year: 2025

🎯 Conclusion

Driven by a deep belief in the power of integration between ancient wisdom and modern science, I have continuously sought to pioneer new frontiers in brain disease treatment. My work has not only advanced research but also nurtured future generations through educational contributions and public science communication. Moving forward, I remain committed to expanding the reach and depth of integrated medicine, aiming to create a lasting legacy of innovation, healing, and academic excellence for global healthcare advancement.

Peng Jun | Cellular Neuroscience | Best Researcher Award

Published on 22/04/2025 by Neuroscientists

Prof. Peng Jun | Cellular Neuroscience | Best Researcher Award

Prof. Peng Jun, Qilu hospital of Shandong University, China.

Professor Jun Peng is a distinguished leader in hematology, currently serving as Vice President of Qilu Hospital of Shandong University and Director of the Department of Hematology. His research is deeply rooted in the immunological pathogenesis and immune tolerance of primary immune thrombocytopenia (ITP), where he has made significant breakthroughs, including the publication of 14 papers in Blood. With a career supported by prestigious national awards, and leadership in 15 high-level research projects, Professor Peng is also a vital figure in Chinese hematology societies and editorial boards of leading journals. His academic rigor, clinical insight, and mentorship continue to shape the future of hematological science in China and beyond.

Profile

Scopus

🎓 Early Academic Pursuits

Professor Jun Peng embarked on his academic journey with a strong commitment to medicine and hematological sciences. From the outset, he exhibited exceptional academic talent and dedication, leading him to pursue both an M.D. and Ph.D. His early education laid a robust foundation for his future specialization in hematology, particularly in the complex field of immunological disorders. His doctoral work, recognized nationally, foreshadowed the groundbreaking contributions he would later make in immune thrombocytopenia research.

🩺 Professional Endeavors

Currently serving as the Vice President of Qilu Hospital of Shandong University, Professor Peng also holds the roles of Chief Physician, Professor, and Ph.D./M.D. Advisor, in addition to being the Director of the Department of Hematology. His clinical and academic responsibilities are carried out with unwavering diligence, mentoring future medical experts while overseeing high-level clinical operations. As a Distinguished Professor of Shandong University, he is actively engaged in shaping the university’s medical excellence on both national and global stages.

🔬 Contributions and Research Focus

At the heart of Professor Peng’s career is his pioneering work on the immunological pathogenesis and immune tolerance of primary immune thrombocytopenia (ITP). He has made substantial contributions to understanding the autoimmune mechanisms that underlie ITP, one of the most challenging hematologic disorders. His scholarly dedication is evidenced by the publication of 14 papers in Blood, a leading journal in hematology, where he served as corresponding or co-corresponding author. His research, grounded in clinical insight and scientific precision, has contributed new perspectives on immune regulation in hematologic diseases.

🏆 Accolades and Recognition

Professor Peng’s excellence has been recognized with numerous prestigious awards. These include the National Science Fund for Distinguished Young Scholars, which highlights his scientific creativity and impact at a young age. He is also a recipient of the One-Hundred National Outstanding Doctoral Dissertation Award, a testament to the academic rigor of his early research. Additionally, he earned the First Prize of the Natural Science Award for Outstanding Achievements in Scientific Research from the Ministry of Education and the Science and Technology Progress Award, reflecting both his academic brilliance and practical impact in the medical field.

🧪 Impact and Influence

Beyond research publications, Professor Peng has significantly influenced the broader scientific and medical communities. As a principal investigator, he has led fifteen national and ministerial-level research projects, including those funded by the National Natural Science Foundation of China and the 973 Program under the Ministry of Science and Technology. His leadership extends to active roles in national academic societies, including the Thrombosis and Hemostasis Group of the Chinese Society of Hematology and the Professional Committee of Experimental Hematology of the Chinese Society of Pathophysiology. These positions allow him to shape the direction of hematological research and clinical guidelines in China.

📚 Academic Leadership and Editorial Roles

A passionate advocate for knowledge dissemination, Professor Peng is a key editorial board member for several respected journals such as Thrombosis Journal, Thrombosis Research, Journal of Clinical Hematology, and the Chinese Journal of Hematology. Through these roles, he ensures that cutting-edge research in hematology is critically evaluated and shared widely, fostering a culture of scientific excellence and collaboration across the globe.

🌟 Legacy and Future Contributions

Professor Jun Peng’s legacy is being forged not only through his past achievements but also through his continued commitment to the advancement of hematological science. His influence spans clinical innovation, academic mentorship, and scientific discovery. As he continues to push the boundaries of understanding in ITP and immune tolerance, he inspires a new generation of physician-scientists. The impact of his work promises to resonate for years to come, offering hope and healing for patients and propelling China’s medical research onto the world stage.

Publication

Title: Autoimmune effector mechanisms associated with a defective immunosuppressive axis in immune thrombocytopenia (ITP)
Authors: Qizhao Li, Geneviève Marcoux, Yuefen Hu, Jung Peng, John W. Semple
Year: 2024

Title: Quantitative detection of macular microvascular abnormalities identified by optical coherence tomography angiography in different hematological diseases
Authors: Tianzi Jian, Fabao Xu, Guihua Li, Li Zhang, Jung Peng
Year: 2024

Title: Nicotinamide enhances Treg differentiation by promoting Foxp3 acetylation in immune thrombocytopenia
Authors: Ju Li, Cheng Zhang, Yuefen Hu, Qi Feng, Xiang Hu
Year: 2024

Title: The effects of complement-independent, autoantibody-induced apoptosis of platelets in immune thrombocytopenia (ITP)
Authors: Lin Sun, Yichen Zhang, Ping Chen, Jung Peng, Zi Sheng
Year: 2024

Title: Post-transplant lymphoproliferative disorders after allogeneic hematopoietic stem cell transplantation: a case report, meta-analysis, and systematic review
Authors: You Yuan Su, Yafei Yu, Zhenyu Yan, Jung Peng, Xinguang Liu
Year: 2024

Title: Ion channel Piezo1 activation aggravates the endothelial dysfunction under a high glucose environment
Authors: Xiaoyu Zhang, Shaoqiu Leng, Xinyue Liu, Shuwen Wang, Jung Peng
Year: 2024

Title: Intelligent dual-modality label-free cell classification with light scattering imaging and Raman spectra measurements
Authors: Faihaa Mohammed Eltigani, Xiaoyu Zhang, Min Liu, Jung Peng, Xuantao Su
Year: 2024

Title: Eltrombopag plus diacerein vs eltrombopag in patients with ITP: a multicenter, randomized, open-label phase 2 trial
Authors: Lu Sun, Xiaoyang Huang, Juan Wang, Ming Hou, Yu Hou
Year: 2024

Title: Risk Factors for Mortality in Critically Ill Patients with Coagulation Abnormalities: A Retrospective Cohort Study
Authors: Qiuyu Guo, Jung Peng, Tichao Shan, Miao Xu
Year: 2024

Title: Platelet-derived TGF-β1 induces functional reprogramming of myeloid-derived suppressor cells in immune thrombocytopenia
Authors: Lingjun Wang, Haoyi Wang, Mingfang Zhu, Ming Hou, Yu Hou
Year: 2024

✅ Conclusion

Through his pioneering research, unwavering clinical dedication, and impactful academic leadership, Professor Jun Peng stands at the forefront of immuno-hematology. His work not only deepens scientific understanding of ITP but also contributes directly to improved patient outcomes. As he continues to inspire through teaching, research, and innovation, Professor Peng’s legacy is one of excellence, influence, and ongoing transformation in the global hematology community.

Burak Derkus | Cellular Neuroscience | Best Researcher Award

Published on 19/04/2025 by Neuroscientists

Prof. Burak Derkus | Cellular Neuroscience | Best Researcher Award

Prof. Burak Derkus, Ankara University, Turkey.

Prof. Burak Derkus has distinguished himself as a pioneering academic and researcher at Ankara University, Turkey, where he has played a vital role in shaping the future of biomedical engineering. His work spans across key disciplines such as biosensors, nanobiotechnology, and lab-on-a-chip technologies. By merging biology with cutting-edge engineering, he has developed innovative solutions aimed at improving diagnostic efficiency and accessibility. His career reflects a balance between scientific discovery, practical application, and educational leadership.

Profile

Google Scholar

🎓 Early Academic Pursuits

From the heart of Turkey, Prof. Burak Derkus began his journey into the world of science and discovery with an unwavering curiosity and dedication. His early academic path was marked by a strong foundation in biomedical sciences, which he cultivated during his undergraduate and postgraduate studies. Prof. Derkus demonstrated exceptional aptitude in analytical thinking and laboratory precision, laying the groundwork for a promising academic future. His formative years were spent exploring the intersections of biology, materials science, and engineering, which later became the pillars of his specialized research focus.

🧪 Professional Endeavors

Prof. Derkus established himself as a dynamic figure in academia through his ongoing association with Ankara University, one of Turkey’s leading research institutions. Here, he contributed not only as a scholar but also as a mentor, actively participating in the development of innovative curriculum modules and engaging students in high-impact research. His professional path is characterized by his interdisciplinary approach, blending principles of nanotechnology, biomedical engineering, and microfabrication to tackle complex challenges in healthcare and diagnostics.

🔬 Contributions and Research Focus

Renowned for his pioneering work in lab-on-a-chip systems, biosensors, and nanobiotechnology, Prof. Derkus has carved out a unique niche in biomedical microdevices. His research focuses on developing miniaturized platforms that can detect diseases with higher sensitivity, speed, and accuracy. By integrating biomaterials with microfluidic technologies, he aims to revolutionize early disease diagnosis and personalized medicine. His published works are rich with innovation, often bridging the gap between engineering and clinical applications.

🏅 Accolades and Recognition

Over the years, Prof. Derkus has earned numerous accolades that reflect his scientific excellence and leadership. His publications in high-impact journals, along with international conference presentations, have positioned him as a thought leader in the biomedical engineering community. He has been invited to serve on editorial boards and scientific committees, further endorsing his reputation as a respected academic figure. These honors underscore his persistent efforts in advancing applied sciences and improving public health through technological innovation.

🌍 Impact and Influence

Prof. Derkus’s influence extends beyond Turkey, resonating across international scientific circles. His research projects have fostered collaborations with institutions across Europe and Asia, facilitating knowledge exchange and cross-border innovation. By mentoring graduate students and young researchers, he continues to inspire a new generation of scientists. His contributions to the development of cost-effective, portable diagnostic tools hold immense potential for global health, particularly in under-resourced communities.

📚 Legacy and Future Contributions

Prof. Derkus is not just a researcher but a visionary thinker. His legacy is being built upon the transformative technologies he develops, aimed at addressing the future needs of society. His ongoing work promises to enhance biomedical diagnostics, therapeutic monitoring, and point-of-care testing. Looking ahead, he is poised to lead larger interdisciplinary collaborations, potentially contributing to the design of smart diagnostic devices powered by artificial intelligence and integrated sensors.

Publication

Title: Supramolecular self-assembly to control structural and biological properties of multicomponent hydrogels
Authors: BO Okesola, Y Wu, B Derkus, S Gani, D Wu, D Knani, DK Smith, …
Year: 2019

Title: Fabrication of human hair keratin/jellyfish collagen/eggshell-derived hydroxyapatite osteoinductive biocomposite scaffolds for bone tissue engineering: From waste to …
Authors: YE Arslan, TS Arslan, B Derkus, E Emregul, KC Emregul
Year: 2017

Title: Applying the miniaturization technologies for biosensor design
Authors: B Derkus
Year: 2016

Title: Myelin basic protein immunosensor for multiple sclerosis detection based upon label-free electrochemical impedance spectroscopy
Authors: B Derkus, E Emregul, C Yucesan, KC Emregul
Year: 2013

Title: Simultaneous quantification of Myelin Basic Protein and Tau proteins in cerebrospinal fluid and serum of Multiple Sclerosis patients using nanoimmunosensor
Authors: B Derkus, PA Bozkurt, M Tulu, KC Emregul, C Yucesan, E Emregul
Year: 2017

Title: Growth‐Factor Free Multicomponent Nanocomposite Hydrogels That Stimulate Bone Formation
Authors: B Okesola, S Ni, B Derkus, C Galeano, A Hasan, Y Wu, J Ramis, L Buttery, …
Year: 2020

Title: Untargeted multi-omic analysis of colorectal cancer-specific exosomes reveals joint pathways of colorectal cancer in both clinical samples and cell culture
Authors: CC Eylem, M Yilmaz, B Derkus, E Nemutlu, CB Camci, E Yilmaz, …
Year: 2020

Title: Multicomponent hydrogels for the formation of vascularized bone-like constructs in vitro
Authors: B Derkus, BO Okesola, DW Barrett, M D’Este, TT Chowdhury, D Eglin, …
Year: 2020

🧭 Conclusion

Prof. Derkus’s journey is a testament to the power of interdisciplinary research and its potential to drive meaningful change in global healthcare. His contributions have not only advanced scientific knowledge but also inspired collaborative innovation on an international scale. With a forward-looking mindset and a deep commitment to societal benefit, he continues to influence the field through research, mentorship, and visionary thinking. As science and medicine evolve, Prof. Burak Derkus remains a guiding force, building a legacy rooted in healing, discovery, and human impact.

Ketan Bulsara | Cellular Neuroscience | Excellence in Neuroscience Research Award

Published on 29/03/2025 by Neuroscientists

Dr. Ketan Bulsara | Cellular Neuroscience | Excellence in Neuroscience Research Award

Dr. Ketan Bulsara, University of Connecticut, United States.

Dr. Ketan Ramanlal Bulsara is a distinguished neurosurgeon, educator, and administrator whose career has been defined by excellence in academic leadership, innovative research, and patient-centered surgical advancements. With a strong foundation in medical education and training, he has held prestigious positions at leading institutions, making significant contributions to the fields of cerebrovascular and skull base surgery. His work in neurosurgical education, healthcare policy, and perioperative quality improvement continues to influence the next generation of medical professionals.

Profile

Google Scholar

🎓 Early Academic Pursuits: The Foundation of Excellence

Dr. Ketan Ramanlal Bulsara’s journey into the world of neurosurgery began with a strong academic foundation. He earned his Bachelor of Science in Biology and Neuroscience, graduating Magna Cum Laude from Davidson College in 1992. His passion for medicine led him to Duke University School of Medicine, where he earned his Medical Degree with Honors in 1996. Committed to mastering his craft, Dr. Bulsara underwent rigorous neurosurgical training at Duke University Medical Center, progressing through internship, residency, and chief residency roles. His dedication to specialized knowledge took him to the University of Iowa for a fellowship in Transoral Surgery and later to Duke’s Neurovascular Program for an advanced Endovascular Fellowship, earning CAST certification by the Senior Neurological Society.

🎉 Professional Endeavors: Pioneering Neurosurgical Excellence

Dr. Bulsara has held esteemed academic and leadership positions throughout his career. Beginning as an Assistant Professor at the University of Missouri, he quickly ascended to directorship roles at Yale University, where he led Neuroendovascular and Skull Base Surgery Programs. His expertise and leadership took him to UConn Health, where he has served as Professor and Chief of Neurosurgery since 2017. As Program Director of UConn’s Neurosurgery Residency Training Program and Director of Operating Room Quality, he has been instrumental in shaping the next generation of neurosurgeons. His administrative impact extended further when he was appointed Interim Inaugural Chairman of UConn’s Department of Neurosurgery in 2024.

📚 Contributions and Research Focus: Advancing Neurosurgical Innovation

Throughout his career, Dr. Bulsara has been at the forefront of neurosurgical research, focusing on cerebrovascular and skull base surgery, neuroendovascular techniques, and perioperative advancements. His tenure at Yale and UConn Health has been marked by groundbreaking contributions to neurosurgical methodologies, patient safety protocols, and cutting-edge surgical interventions. With a keen interest in medical policy and administration, he also serves as Chair of the UConn Health/University of Connecticut Dean’s Task Force on Coding and Documentation, ensuring optimal standards in medical practice.

🏆 Accolades and Recognition: A Trailblazer’s Achievements

Dr. Bulsara’s exemplary work has earned him widespread recognition in academic, clinical, and administrative spheres. His leadership has been pivotal in strengthening neurosurgical departments and residency programs, earning respect from peers and students alike. His continued commitment to excellence led him to pursue an Executive MBA at Yale School of Management, which he completed in 2017, equipping him with advanced skills in healthcare management and strategic planning. Furthering his multidisciplinary expertise, he embarked on a legal education at the University of Connecticut School of Law in 2024, highlighting his commitment to integrating medicine, business, and law for the betterment of healthcare.

💡 Impact and Influence: Shaping the Future of Neurosurgery

Dr. Bulsara’s influence extends far beyond the operating room. As a mentor, he has trained and guided numerous neurosurgeons, instilling in them the values of precision, innovation, and patient-centered care. His research and administrative contributions have shaped hospital policies and perioperative strategies, leading to improved surgical outcomes and enhanced healthcare delivery systems. His work in academic leadership continues to bridge the gap between medical practice, research, and education.

Publication

Spinal axon regeneration evoked by replacing two growth cone proteins in adult neurons – HM Bomze, KR Bulsara, BJ Iskandar, P Caroni, JH Pate Skene (2001)

Longitudinal molecular trajectories of diffuse glioma in adults – FP Barthel, KC Johnson, FS Varn, AD Moskalik, G Tanner, E Kocakavuk, et al. (2019)

Glioma progression is shaped by genetic evolution and microenvironment interactions – FS Varn, KC Johnson, J Martinek, JT Huse, MLP Nasrallah, P Wesseling, et al. (2022)

Accuracy of prediction instruments for diagnosing large vessel occlusion in individuals with suspected stroke: a systematic review for the 2018 guidelines for the early… – EE Smith, DM Kent, KR Bulsara, LY Leung, JH Lichtman, MJ Reeves, et al. (2018)

Perioperative complications in transforaminal lumbar interbody fusion versus anterior–posterior reconstruction for lumbar disc degeneration and instability – AT Villavicencio, S Burneikiene, KR Bulsara, JJ Thramann (2006)

Vessel wall magnetic resonance imaging identifies the site of rupture in patients with multiple intracranial aneurysms: proof of principle – CC Matouk, DM Mandell, M Günel, KR Bulsara, A Malhotra, R Hebert, et al. (2013)

Safety of transforaminal lumbar interbody fusion and intervertebral recombinant human bone morphogenetic protein—2 – AT Villavicencio, S Burneikiene, EL Nelson, KR Bulsara, M Favors, et al. (2005)

Laminectomy versus percutaneous electrode placement for spinal cord stimulation – AT Villavicencio, JC Leveque, L Rubin, K Bulsara, JP Gorecki (2000)

Indications for thrombectomy in acute ischemic stroke from emergent large vessel occlusion (ELVO): report of the SNIS Standards and Guidelines Committee – M Mokin, SA Ansari, RA McTaggart, KR Bulsara, M Goyal, M Chen, et al. (2019)

Review of the literature on de novo formation of cavernous malformations of the central nervous system after radiation therapy – SM Nimjee, CJ Powers, KR Bulsara (2006)

💪 Conclusion

A visionary in neurosurgery, Dr. Bulsara’s impact transcends surgical practice, reaching into medical education, research, and healthcare administration. His multidisciplinary approach—combining medicine, business, and law—positions him as a leader in shaping the future of healthcare. His commitment to innovation and excellence ensures that his contributions will continue to elevate neurosurgical standards and inspire future generations of medical professionals.

Daša Zupančič | Cellular Neuroscience | Best Researcher Award

Published on 29/03/2025 by Neuroscientists

Assoc. Prof. Dr. Daša Zupančič | Cellular Neuroscience | Best Researcher Award

Assoc. Prof. Dr. Daša Zupančič, Faculty of Medicine, University of Ljubljana, Slovenia.

Daša Zupančič is a distinguished academic and researcher specializing in cell biology, urothelial pathology, and medical education. Her extensive contributions to scientific research, particularly in the field of urothelial repair and cancer transformation, have earned her recognition, including the EMBO award. She has played a crucial role in mentoring and teaching, guiding future generations of researchers and medical professionals.

Profile

Orcid

✨ Early Academic Pursuits ✨

Daša Zupančič embarked on her academic journey with an unwavering passion for cell biology and medicine. She earned her Master’s degree in 2002 from the University of Ljubljana, Faculty of Medicine, where she meticulously explored cellular and molecular biological changes in the rat bladder urothelium following cyclophosphamide exposure. This formative research laid the foundation for her Ph.D., which she successfully completed in 2006, investigating the protective role of melatonin in urothelial injury and repair. Her dedication to advancing biomedical knowledge was evident from the very beginning of her scholarly career.

🎓 Professional Endeavors 🎓

Since 2006, Daša Zupančič has been an esteemed Associate Professor at the University of Ljubljana, Faculty of Medicine, Institute of Cell Biology. Prior to this, she gained valuable experience as a Young Researcher and Teaching Assistant from 1999 to 2006. Her extensive expertise and commitment to education have made her an integral part of the institution, where she continuously fosters scientific curiosity and excellence among students and colleagues alike.

🎡 Contributions and Research Focus 🎡

Throughout her career, Daša Zupančič has dedicated her research to understanding cellular mechanisms in urothelial biology and pathology. Her investigations into cyclophosphamide-induced urothelial injury, melatonin’s protective effects, and retinoid signaling pathways in urothelial cancer transformation have provided valuable insights into cellular repair processes. Her work extends beyond laboratory research, influencing the medical community’s approach to urothelial diseases and potential therapeutic advancements.

🏆 Accolades and Recognition 🏆

Her exceptional contributions to biomedical research have been recognized on multiple platforms. In 2017, she was honored with the prestigious EMBO award for her short-term scholarship project on the role of the retinoid signaling pathway in urothelial cancer transformation. This recognition underscores her significant impact on the scientific community and highlights her pioneering approach to understanding cancer pathophysiology.

👨‍🎓 Impact and Influence 👨‍🎓

A dedicated mentor, Daša Zupančič has guided numerous students towards academic excellence. Between 2014 and 2025, she has successfully mentored four master’s students and is currently supervising two more. In addition, she has overseen the research endeavors of four Ph.D. candidates, with one having successfully defended their dissertation in 2023 and another expected to graduate in 2025. Her mentorship has shaped the next generation of biomedical researchers, fostering a culture of rigorous inquiry and scientific discovery.

📚 Legacy and Future Contributions 📚

Beyond her research, Daša Zupančič plays a pivotal role in academia through her extensive teaching engagements. Since 2000, she has been a cornerstone of education at the University of Ljubljana, contributing to multiple faculties, including Medicine, Biotechnical Sciences, Health Sciences, and Pharmacy. She teaches a range of graduate and doctoral courses, covering essential subjects such as Medical Cell Biology, Immunology, and Research in Medicine. Her dedication to education ensures that her knowledge and expertise continue to shape the minds of aspiring medical professionals and researchers for years to come.

Publication

Vitamin A‐Enriched Diet Increases Urothelial Cell Proliferation by Upregulating Itga3 and Areg After Cyclophosphamide‐Induced Injury in Mice
Authors: Brina Dragar, Simona Kranjc Brezar, Maja Čemažar, Tanja Jesenko, Rok Romih, Mateja Erdani Kreft, Tadeja Kuret, Daša Zupančič
Year: 2025

Selective Targeting of Lectins and Their Macropinocytosis in Urothelial Tumours: Translation from in vitro to ex vivo
Authors: Nataša Resnik, Tanja Višnjar, Tomaž Smrkolj, Mateja Erdani Kreft, Rok Romih, Daša Zupančič
Year: 2023

Nanodiamonds as Possible Tools for Improved Management of Bladder Cancer and Bacterial Cystitis
Authors: Daša Zupančič, Peter Veranič
Year: 2022

Transmission Electron Microscopy Demonstration of Reduced Endothelial Glycocalyx in Severe Preeclampsia
Authors: Mugerli S, Zupančič D, Rok Romih, Lučovnik M
Year: 2022

Vitamin A and Retinoids in Bladder Cancer Chemoprevention and Treatment: A Narrative Review of Current Evidence, Challenges and Future Prospects
Authors: Larisa Tratnjek, Jera Jeruc, Rok Romih, Daša Zupančič
Year: 2021

Immunohistochemistry as a Paramount Tool in Research of Normal Urothelium, Bladder Cancer and Bladder Pain Syndrome
Authors: Daša Zupančič, Rok Romih
Year: 2021

Combined Lectin- and Immuno-Histochemistry (CLIH) for Applications in Cell Biology and Cancer Diagnosis: Analysis of Human Urothelial Carcinomas
Authors: Daša Zupančič
Year: 2020

Vitamin A Rich Diet Diminishes Early Urothelial Carcinogenesis by Altering Retinoic Acid Signaling
Authors: Daša Zupančič, Jelena Korać-Prlić, Mateja Erdani Kreft, Lucija Franković, Katarina Vilović, Jera Jeruc, Rok Romih, Janoš Terzić
Year: 2020

Lectins as Possible Tools for Improved Urinary Bladder Cancer Management
Authors: Daša Zupančič
Year: 2019

Co-Culturing Porcine Normal Urothelial Cells, Urinary Bladder Fibroblasts and Smooth Muscle Cells for Tissue Engineering Research
Authors: Daša Zupančič
Year: 2018

🌟 Conclusion 🌟

With a career dedicated to pioneering research, impactful mentorship, and transformative education, Daša Zupančič continues to leave a lasting legacy in the scientific and academic communities. Her work not only enhances understanding of urothelial biology but also inspires innovation and discovery among young scientists. As she continues her academic and research endeavors, her influence on the field will undoubtedly grow, shaping the future of biomedical sciences.

Elissavet Kollia | Developmental Neuroscience |Best Researcher Award

Published on 08/03/202508/03/2025 by Neuroscientists

Ms. Elissavet Kollia | Developmental Neuroscience |Best Researcher Award

Ms. Elissavet Kollia, National Kapodistrian University of Athens, Greece.

Ms. Elissavet Kollia is a distinguished pediatrician and researcher specializing in pediatric neurology. With an exceptional academic background, she graduated from the Medical School of the Democritus University of Thrace and pursued advanced postgraduate studies in Clinical Pediatrics and Nursing-Research. Her extensive clinical training, from pediatrics specialization to her current role at Konstantopouleio General Hospital “Agia Olga,” has solidified her expertise in child healthcare. Additionally, her research focuses on movement disorders in pediatric patients with early-onset developmental and epileptic encephalopathy, contributing valuable insights to the field. Her dedication extends beyond clinical practice, as seen in her voluntary medical work and commitment to mentoring young professionals.

Profile

Google Scholar

🎓 Early Academic Pursuits

From an early age, Elissavet Kollia demonstrated exceptional academic abilities, graduating from the 4th General Lyceum of Agia Paraskevi with an outstanding general grade of “excellent 19.2.” Her passion for medicine led her to the Medical School of the Democritus University of Thrace, where she was admitted in September 2007. With dedication and perseverance, she successfully earned her medical degree in July 2013, achieving a commendable grade of “very good 8.33.” Shortly after, she obtained her license to practice as a doctor in Greece and later in Munich, Germany, reflecting her international medical competence.

🏥 Professional Endeavors

Ms. Kollia’s professional journey has been marked by extensive clinical training and hands-on experience in pediatrics. She began her specialization at the Pediatric Clinic of the General Hospital of Karpenisi from June 2014 to October 2016. Her commitment to healthcare extended beyond hospitals as she served as a rural doctor at the Primary Health Care Center of Agios Nikolaos, Evrytania, actively participating in emergency care at the General Hospital of Karpenisi. Her expertise deepened when she became a scientific associate at the Pediatric Neurology Unit of the First Pediatric Clinic of the National University of Athens. She then pursued her residency in pediatrics at the First University Pediatric Clinic – Children’s Hospital “Agia Sophia” from November 2018 to May 2022, ultimately obtaining her specialty title in June 2022. Currently, she is serving as a pediatrician at the Konstantopouleio General Hospital “Agia Olga,” continuing her mission to provide excellent pediatric care.

📝 Contributions and Research Focus

Ms. Kollia’s dedication to medical research has significantly contributed to the field of pediatric neurology. Her postgraduate studies in “Clinical Pediatrics and Nursing-Research,” completed with an exceptional grade of “Excellent 9.31,” strengthened her academic foundation. Her ongoing doctoral dissertation at the National Kapodistrian University of Athens focuses on movement disorders in pediatric patients with early-onset developmental and epileptic encephalopathy, a field crucial for advancing neurological care in children. Her research efforts have led to an upcoming publication in the European Journal of Paediatric Neurology, further establishing her as a valuable contributor to the scientific community.

🌟 Accolades and Recognition

Ms. Kollia’s unwavering commitment to medicine has been recognized through her outstanding academic achievements and professional milestones. From excelling in her graduate and postgraduate studies to securing prestigious residency and specialization opportunities, she has consistently demonstrated excellence in her field. Her acceptance into renowned institutions and her involvement in vital research projects underline her credibility and expertise in pediatric neurology.

💪 Impact and Influence

Beyond her clinical and academic contributions, Dr. Kollia has actively participated in voluntary medical programs, extending her expertise to underserved populations. She contributed to emergency case observations at the Children’s Hospital “Agia Sophia” and participated in medical landing programs in remote islands, showcasing her dedication to public health. Her influence extends to mentoring young medical professionals, sharing her knowledge, and contributing to the medical community’s growth.

💡 Legacy and Future Contributions

With a passion for advancing pediatric neurology, Dr. Kollia continues to shape the future of medical research and patient care. Her work in understanding movement disorders in children with epileptic encephalopathy holds the potential to improve diagnostic and therapeutic approaches in pediatric neurology. As she progresses in her career, her contributions to both clinical practice and scientific research will undoubtedly leave a lasting impact on the medical community and the lives of the children she treats.

Publication

Title: The genetic etiology in cerebral palsy mimics: the results from a Greek tertiary care center
Authors: V Zouvelou, D Yubero, L Apostolakopoulou, E Kokkinou, M Bilanakis, …
Year: 2019

Title: MOTOR PHENOTYPING IN A GREEK COHORT OF PATIENTS WITH NEONATAL AND INFANTILE ONSET DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY
Authors: E Kollia, E Kokkinou, C Outsika, G Koltsida, V Zouvelou, A Vontzalidis, …
Year: 2025

🌟 Conclusion

Ms. Kollia’s journey exemplifies the perfect blend of academic excellence, professional expertise, and compassionate patient care. Through her research and clinical endeavors, she continues to advance the understanding and treatment of pediatric neurological disorders. Her unwavering dedication to improving children’s health positions her as a leading figure in pediatric medicine. With her vision for excellence and continued contributions, she is set to leave a lasting impact on the medical field, inspiring future generations of healthcare professionals.

Vikash Kumar | Molecular Biology | Best Researcher Award

Published on 05/03/202507/03/2025 by Neuroscientists

Dr. Vikash Kumar | Molecular Biology | Best Researcher Award

Dr. Vikash Kumar, Central Inland Fisheries Research Institute, India.

Dr. Vikash Kumar is a distinguished scientist in the field of aquaculture and fish health management, with over 15 years of research experience. His academic journey, from earning a Ph.D. with distinction at Ghent University to holding key research positions at ICAR-CIFRI, has been marked by excellence. His expertise spans transcriptomics, proteomics, cellular biology, and immunohistochemistry, with a strong focus on understanding fish and shrimp immunological responses. His groundbreaking research on Acute Hepatopancreatic Necrosis Disease (AHPND) in shrimp and inflammation in Labeo rohita has significantly contributed to disease mitigation strategies in aquaculture. Recognized among the Top 2% of Scientists globally (Stanford/Elsevier, 2024), Dr. Kumar’s influence extends beyond research, shaping policies and fostering international collaboration.

profile

Google Scholar

🎓 Early Academic Pursuits

Dr. Vikash Kumar’s journey into the world of aquaculture and fish health began with a strong academic foundation. With a Bachelor of Fisheries Science from the College of Fisheries, India, he excelled in his studies, earning first-class distinction with an impressive 8.66/10.0 GPA. Building upon this, he pursued a Master of Fisheries Science in Fish Health from ICAR-Central Institute of Fisheries Education (CIFE), India, where he once again showcased academic brilliance, securing an 8.23/10.0 GPA. His thirst for knowledge and dedication to research led him to Belgium, where he earned his Ph.D. from the esteemed Laboratory of Aquaculture & Artemia Reference Center, Ghent University, in 2020. Awarded with distinction, his doctoral studies solidified his expertise in fish and shrimp immunology, setting the stage for a remarkable scientific career.

🏅 Professional Endeavors

With more than 15 years of experience in aquaculture and fish health management, Dr. Kumar has made significant strides in his field. His professional journey began in 2014 as a Scientist at the ICAR-Central Inland Fisheries Research Institute (ICAR-CIFRI) in Kolkata, India. After four years of dedicated service, he embarked on his doctoral research at Ghent University, where he explored critical aspects of aquatic immunology. Returning to ICAR-CIFRI in 2020 as a Senior Scientist, he continues to contribute to the advancement of fisheries research, working with diverse stakeholders and scientists to address pressing challenges in the aquaculture industry.

🔬 Contributions and Research Focus

Dr. Kumar’s research spans a broad spectrum of critical topics in aquaculture. His expertise in transcriptomics, proteomics, cellular biology, histology, immunohistochemistry, and electron microscopy has enabled him to unravel complex immunological responses in fish and shrimp. His work has provided invaluable insights into the virulence and pathogenesis of Acute Hepatopancreatic Necrosis Disease (AHPND) in shrimp, leading to the development of innovative mitigation strategies. Additionally, his research on carrageenan-induced inflammation in Labeo rohita has contributed to a deeper understanding of fish immune responses, paving the way for improved disease management in aquaculture.

🏆 Accolades and Recognition

Dr. Kumar’s contributions to fisheries science have earned him global recognition. He is ranked among the Top 2% of Scientists worldwide as per Stanford/Elsevier rankings in 2024, a testament to his impactful research and scientific excellence. His work is widely acknowledged in the scientific community, reflecting his dedication to enhancing the health and sustainability of aquatic species. His commitment to continuous learning and innovation has made him a respected figure in fisheries research, both in India and internationally.

🌍 Impact and Influence

Dr. Kumar’s research has significantly influenced disease management strategies in aquaculture, directly benefiting the fisheries industry. His work has helped improve diagnostic methods, develop novel treatment approaches, and enhance the overall resilience of aquaculture systems against infectious diseases. His ability to collaborate with researchers worldwide has fostered the exchange of knowledge, strengthening the global scientific network dedicated to sustainable aquaculture practices.

🔬 Legacy and Future Contributions

As a dedicated scientist, Dr. Kumar’s legacy is defined by his relentless pursuit of solutions for aquaculture challenges. His research continues to inspire young scientists, and his contributions are shaping the future of fish health management. Moving forward, he aims to expand his studies on disease mitigation strategies, explore cutting-edge biotechnological approaches, and contribute to policy frameworks that promote sustainable fisheries. His unwavering commitment to scientific advancement ensures that his impact will resonate for generations to come.Dr. Vikash Kumar stands as a beacon of excellence in aquaculture research, transforming the field with his expertise, passion, and vision for a healthier aquatic future.

publication

Genus Bacillus, Promising Probiotics in Aquaculture: Aquatic Animal Origin, Bio-Active Components, Bioremediation and Efficacy in Fish and Shellfish
Authors: M Soltani, K Ghosh, SH Hoseinifar, V Kumar, AJ Lymbery, S Roy, E Ringø
Year: 2019

Application of Probiotics in Shrimp Aquaculture: Importance, Mechanisms of Action, and Methods of Administration
Authors: V Kumar, S Roy, DK Meena, UK Sarkar
Year: 2016

Acute Hepatopancreatic Necrosis Disease (AHPND): Virulence, Pathogenesis and Mitigation Strategies in Shrimp Aquaculture
Authors: V Kumar, S Roy, BK Behera, P Bossier, BK Das
Year: 2021

Immunostimulants for Aquaculture Health Management
Authors: D Barman, P Nen, SC Mandal, V Kumar
Year: 2013

A Practical Approach on SDS PAGE for Separation of Protein
Authors: S Roy, V Kumar
Year: 2014

Phloroglucinol-Mediated Hsp70 Production in Crustaceans: Protection Against Vibrio Parahaemolyticus in Artemia Franciscana and Macrobrachium Rosenbergii
Authors: V Kumar, K Baruah, DV Nguyen, G Smagghe, E Vossen, P Bossier
Year: 2018

Biofloc Microbiome with Bioremediation and Health Benefits
Authors: V Kumar, S Roy, BK Behera, BK Das
Year: 2021

Acute Phase Proteins and Their Potential Role as an Indicator for Fish Health and in Diagnosis of Fish Diseases
Authors: S Roy, V Kumar, V Kumar, BK Behera
Year: 2017

Conclusion

Dr. Vikash Kumar’s contributions to aquaculture science are both profound and far-reaching. His work not only advances scientific understanding but also provides practical solutions for the sustainable growth of the fisheries industry. His dedication to innovation, research, and global collaboration cements his status as a leading scientist in his field. As he continues his pursuit of excellence, his impact on aquatic health management will undoubtedly shape the future of sustainable aquaculture and inspire upcoming generations of researchers. 🌊🐠

Pongrama Ramasoota | Molecular and Cellular Neuroscience | Best Researcher Award

Published on 28/02/202528/02/2025 by Neuroscientists

Prof. Dr. Pongrama Ramasoota | Molecular and Cellular Neuroscience | Best Researcher Award

Prof. Dr. Pongrama Ramasoota, Mahidol University, Thailand.

Dr. Pongrama Ramasoota is a distinguished professor and researcher specializing in antibody research and virology at the Centre of Excellence for Antibody Research (CEAR), Mahidol University, Thailand. With a strong academic foundation in veterinary medicine, public health, and microbiology, he has dedicated his career to developing therapeutic and diagnostic monoclonal antibodies against viruses such as Dengue, Rabies, Foot and Mouth Disease, and Influenza. His contributions extend beyond infectious disease research, as he has also explored anti-aging supplements for humans and pets. Recognized with numerous national and international awards, his research has significantly impacted medical biotechnology, earning him a reputation as a leading scientist in his field.

Profile

Scopus

🎓 Early Academic Pursuits

Pongrama Ramasoota’s journey into the world of microbiology and antibody research began with a solid foundation in veterinary medicine. He earned his Doctor of Veterinary Medicine from Kasetsart University, where his fascination with infectious diseases and immunology took root. His academic pursuits led him to Mahidol University, where he obtained a Master of Public Health, further broadening his expertise in disease prevention and control. Driven by a passion for scientific exploration, he pursued a Master of Science and Ph.D. in Microbiology at the prestigious Swedish University of Agricultural Sciences in Uppsala, Sweden. These formative years were instrumental in shaping his career as a leading researcher in antibody development and disease management.

🏥 Professional Endeavors

As a distinguished professor at the Centre of Excellence for Antibody Research (CEAR) within the Faculty of Tropical Medicine, Mahidol University, Dr. Ramasoota has dedicated his career to advancing the field of immunotherapy. His research primarily focuses on developing neutralizing monoclonal antibodies to combat viral threats such as Dengue and Rabies. Over the years, he has led groundbreaking projects aimed at creating effective therapeutic and diagnostic solutions. His expertise has also extended beyond academia, as he collaborates with industry leaders to translate research into practical applications that benefit global health.

🦠 Contributions and Research Focus

Dr. Ramasoota’s contributions to medical research are vast and impactful. His work on neutralizing human monoclonal antibodies against Dengue and Rabies viruses has paved the way for potential life-saving treatments. His research extends to diagnostic monoclonal antibodies for detecting Foot and Mouth Disease Virus (FMDV) and Influenza, significantly enhancing disease surveillance. Beyond infectious diseases, he has also ventured into anti-aging research, developing natural supplements to promote longevity in both humans and pets. His relentless pursuit of innovation continues to drive advancements in virology, immunotherapy, and biotechnology.

🏆 Accolades and Recognition

Dr. Ramasoota’s contributions to science have been recognized with numerous prestigious awards. He was honored as Thailand’s Outstanding Researcher in 2020 and named Thailand’s Outstanding Veterinarian in 2016. His innovative work earned him multiple Outstanding Research and Invention Awards from the National Research Council of Thailand between 2008 and 2016. He has also received international recognition, including a gold medal from the 2014 Taipei Invention & Techno Mart and awards from the Korea Invention Association and the International Federation of Inventors’ Associations. These accolades underscore his influence as a pioneer in antibody research and biotechnology.

🌍 Impact and Influence

With an H-index of 18 and over 1,038 citations on Scopus, Dr. Ramasoota’s research has significantly influenced the scientific community. His findings have been instrumental in shaping new treatment strategies for viral diseases, providing hope for better therapeutic interventions. Collaborating with industry leaders such as Advy Chemical (India) and Thai-Naoka (Thailand), he has helped bridge the gap between research and real-world applications. His contributions to diagnostic tools and monoclonal antibody therapies continue to shape the future of virology and medical biotechnology.

📚 Legacy and Future Contributions

Beyond his research endeavors, Dr. Ramasoota has authored books that highlight his expertise in environmental management and anti-aging technologies. His book Hallmarks of Aging, Technology and Innovation for Anti-Aging explores groundbreaking advancements in longevity research, demonstrating his commitment to improving human health across various dimensions. As he continues to innovate, his legacy as a leading researcher in antibody development and viral immunotherapy will inspire future generations of scientists. His ongoing efforts to combat infectious diseases and promote healthier aging promise a lasting impact on global health and biotechnology.

Publication

Title: Development of novel canine phage display-derived neutralizing monoclonal antibody fragments against rabies virus from immunized dogs
Authors: A. Chorpunkul, U. Boonyuen, K. Limkittikul, P. Lekcharoensuk, P. Ramasoota
Year: 2024

Title: Characterization of Vibrio parahaemolyticus isolated from clinical specimens and oysters in Thailand
Authors: N. Tewawong, S. Kowaboot, S. Kengkarn, P. Ramasoota, O. Suthienkul
Year: 2024

Title: Nicotiana benthamiana as a potential source for producing anti-dengue virus D54 neutralizing therapeutic antibody
Authors: S. Krittanai, K. Rattanapisit, C.J.I. Bulaon, R. Strasser, W. Phoolcharoen
Year: 2024

Title: Associations of effort-reward imbalance at work and quality of life among workers after stroke: a one-year longitudinal study in Thailand
Authors: S. Naknoi, J. Li, P. Ramasoota, N. Soonthornworasiri, O. Kaewboonchoo
Year: 2023

Title: Potential Protective Effect of Dengue NS1 Human Monoclonal Antibodies against Dengue and Zika Virus Infections
Authors: R. Sootichote, W. Puangmanee, S. Benjathummarak, P. Ramasoota, P. Pitaksajjakul
Year: 2023

Title: A replication competent luciferase-secreting DENV2 reporter for sero-epidemiological surveillance of neutralizing and enhancing antibodies
Authors: K. Saipin, B.K. Thaisomboonsuk, B. Siridechadilok, N. Sittisombut, J. Junjhon
Year: 2022

Title: Spread of a Novel Indian Ocean Lineage Carrying E1‐K211E/E2‐V264A of Chikungunya Virus East/Central/South African Genotype across the Indian Subcontinent, Southeast Asia, and Eastern Africa
Authors: J. Phadungsombat, H.A. Imad, E.E. Nakayama, W. Piyaphanee, T. Shioda
Year: 2022

🎯 Conclusion

Dr. Ramasoota’s work has not only advanced scientific knowledge but also contributed to real-world solutions in disease treatment and diagnostics. His collaborations with industries and commitment to innovation ensure that his research continues to benefit global health. As he continues to push the boundaries of antibody research and anti-aging science, his legacy will inspire future generations of scientists, leaving a lasting impact on virology, immunotherapy, and biotechnology.

Shilin Luo | Neurogenetics and Molecular Neuroscience | Best Researcher Award

Published on 17/02/202517/02/2025 by Neuroscientists

Prof. Shilin Luo | Neurogenetics and Molecular Neuroscience | Best Researcher Award

Prof. Shilin Luo, Xiangya Hospital, Central South University, China.

Dr. Shilin Luo is a leading expert in neuropharmacology and medicinal chemistry, with a strong academic background in traditional Chinese medicine and modern pharmacology. His research focuses on the pathogenesis of neurodegenerative diseases and the development of innovative drug therapies. Through his work at Xiangya Hospital, Central South University, and previous research at Emory University, he has made significant contributions to understanding neurological disorders. His studies on animal models and risk genes have paved the way for novel treatment strategies, earning him international recognition.

Profile

Scopus

Orcid

🎓 Early Academic Pursuits

Dr. Shilin Luo’s journey into the world of medical science began with a deep-rooted passion for understanding the complexities of neurological diseases. He earned his Bachelor’s degree in Chinese Materia Medica from Shenyang Pharmaceutical University, where he developed a strong foundation in traditional Chinese medicine and pharmacology. With an insatiable thirst for knowledge, he further pursued a Ph.D. in Medicinal Chemistry at China Pharmaceutical University, specializing in the research of active ingredients in natural products. Under the mentorship of Prof. Wencai Ye, a distinguished scholar, Dr. Luo honed his expertise in medicinal chemistry, paving the way for groundbreaking discoveries in neuropharmacology.

👨‍🎓 Professional Endeavors

To deepen his expertise, Dr. Luo embarked on postdoctoral research at Emory University’s School of Medicine in the Department of Pathology and Laboratory Medicine. Working under the esteemed Prof. Keqiang Ye, he focused on neurobiology and neuropharmacology, contributing significantly to the understanding of neurodegenerative diseases. His research provided novel insights into the molecular mechanisms underlying neurological disorders, positioning him as a leading figure in the field. He later took on a pivotal role as a professor in the Department of Neurology at Xiangya Hospital, Central South University, where he continues to mentor young scientists and advance medical research.

🧪 Contributions and Research Focus

Dr. Luo’s research is primarily dedicated to uncovering the pathogenesis of neurodegenerative diseases and developing therapeutic interventions. His work in animal models of pathogenic and risk genes for neurological disorders has been instrumental in identifying potential drug targets. By integrating traditional Chinese medicine with modern pharmacology, he has contributed to the development of innovative neuroprotective agents. His studies on the molecular mechanisms of neuronal degeneration have led to promising advancements in combating conditions such as Alzheimer’s and Parkinson’s disease.

🏆 Accolades and Recognition

Throughout his career, Dr. Luo has been widely recognized for his groundbreaking contributions to neuropharmacology. His research has been published in high-impact scientific journals, earning him international acclaim. His dedication to scientific excellence has garnered prestigious awards, and he is frequently invited to deliver keynote lectures at global conferences. His work continues to inspire fellow researchers, solidifying his reputation as a distinguished scientist in neurological drug development.

🏰 Impact and Influence

Dr. Luo’s impact extends beyond the laboratory, as he actively contributes to the medical community through mentorship and collaboration. His efforts in integrating traditional Chinese medicinal principles with cutting-edge pharmacological approaches have opened new avenues for drug discovery. His research findings have not only influenced academic discourse but have also laid the groundwork for potential clinical applications, bringing hope to patients suffering from neurodegenerative diseases.

⚛️ Legacy and Future Contributions

As a visionary scientist, Dr. Luo continues to push the boundaries of neurological research. His commitment to translational medicine aims to bridge the gap between laboratory discoveries and clinical applications. By fostering interdisciplinary collaborations and mentoring the next generation of researchers, he is shaping the future of neuropharmacology.

Publication

Disease-modifying therapies for Alzheimer’s disease: Clinical trial progress and opportunity
Authors: Yujie Zhang, Jie Chen, Yanru Li, Bin Jiao, Shilin Luo
Year: 2025

The role of the probiotic Akkermansia muciniphila in brain functions: insights underpinning therapeutic potential
Authors: Ruiling Xu, Yuxuan Zhang, Shurui Chen, Yaohui Zeng, Xuan Fu, Ti Chen, Shilin Luo, Xiaojie Zhang
Year: 2023

Nonviral delivery systems for antisense oligonucleotide therapeutics
Authors: Si Huang, Xin-Yan Hao, Yong-Jiang Li, Jun‑Yong Wu, Da-Xiong Xiang, Shilin Luo
Year: 2022

The Microglial membrane receptor TREM2 mediates exosome secretion to promote phagocytosis of amyloid‐β by microglia
Authors: Si Huang, Xiaoli Liao, Junyong Wu, Xiaojie Zhang, Yamin Li, Daxiong Xiang, Shilin Luo
Year: 2022

Correction: Microglial ERK-NRBP1-CREB-BDNF signaling in sustained antidepressant actions of (R)-ketamine
Authors: Not explicitly listed
Year: 2021

Polygonatum sibiricum Polysaccharides Protect against MPP‐Induced Neurotoxicity via the Akt/mTOR and Nrf2 Pathways
Authors: Si Huang, Haiyan Yuan, Wenqun Li, Xinyi Liu, Xiaojie Zhang, Daxiong Xiang, Shilin Luo, Guodong Zhang
Year: 2021

Bushen-Tiansui Formula Improves Cognitive Functions in an Aβ1–42 Fibril-Infused Rat Model of Alzheimer’s Disease
Authors: Chenxia Sheng, Panpan Xu, Xinyi Liu, Weijun Peng, Daxiong Xiang, Shilin Luo
Year: 2020

Osteogenesis activity of isocoumarin a through the activation of the PI3K-Akt/Erk cascade-activated BMP/RUNX2 signaling pathway
Authors: Not explicitly listed
Year: 2019

Akt Phosphorylates NQO1 and Triggers its Degradation, Abolishing Its Antioxidative Activities in Parkinson’s Disease
Authors: Shilin Luo, Seong Su Kang, Zhi-Hao Wang, Xia Liu, Julia X Day, Zhiping Wu, Junmin Peng, Daxiong Xiang, Wolfdieter Springer, Keqiang Ye
Year: 2019

Puerarin-loaded PEG-PE micelles with enhanced anti-apoptotic effect and better pharmacokinetic profile
Authors: Not explicitly listed
Year: 2018

Conclusion

Dr. Luo’s unwavering dedication to neurological research continues to shape the future of neuropharmacology. His innovative approach, combining traditional medicinal insights with modern scientific advancements, has the potential to revolutionize drug development for neurodegenerative diseases. As a mentor, researcher, and pioneer in his field, his contributions will leave a lasting impact on both academia and clinical medicine, offering hope for more effective treatments in the years to come.

Hamid khan | Molecular and Cellular Neuroscience | Young Scientist Award

Published on 25/09/2024 by Neuroscientists

Mr.Hamid khan | Molecular and Cellular Neuroscience | Young Scientist Award

Mr. Hamid khan Icahn School of Medicine at Mount Sinai, New York Pakistan

Hamid Khan is a dedicated researcher and educator who recently completed his PhD in Biotechnology, specializing in Human Molecular Genetics. His academic journey includes a strong foundation in biological sciences, evidenced by his educational background ranging from a BSc to a PhD, with a focus on genetic analysis of rare congenital disorders. His doctoral research has provided insights into the genetic basis of autism spectrum disorder (ASD) and oculocutaneous albinism, contributing significantly to the understanding of these conditions.

profile

scholar

🎓 Education

PhD in Biotechnology (Human Molecular Genetics)International Islamic University Islamabad, Pakistan & University of Toronto, Canada (2018-2024).MS/M.Phil in Biotechnology (Human Molecular Genetics)International Islamic University Islamabad, Pakistan (2016-2018).M.Sc in ZoologyHazara University Mansehra, KPK, Pakistan (2011-2013).B.Sc in Biological Science (Botany, Zoology, Chemistry)University of Peshawar, Pakistan (2008-2010).H.S.S.C Pre-Medical
Peshawar Board, Pakistan (2006-2008)S.S.C Science SubjectsPeshawar Board, Pakistan (2004-2006).B.Ed in Education
Sarhad University of Science & Information Technology (2014).CT Certified TeacherAllama Iqbal Open University (2016).

🔬 Research Experience

Researcher at Biomolecular Genetic Engineering Lab, International Islamic University Islamabad (4 years).Research Associate in Pak-US Science and Technology Cooperation Program (1 year).Researcher in MiND Laboratory, Campbell Family Mental Health Research Institute, Toronto, Canada (6 months)

💼 Work Experience

Visiting Lecturer at Department of Biological Sciences, IIUI (3 years).Lecturer at IQRA College of Technology, IIUI (2 years)

🛠️ Skills

Laboratory Skills: PCR, NGS data analysis, Microarray, Gene Cloning, Cell Culturing, etc.Computer Skills: Python, Sentieon, Verseq, Exomiser, Excel, PowerPoint, Word.

🏆 Awards

IRSIP Award from the Higher Education Commission (HEC) Pakistan.First position holder in PhD coursework.Selected as Research Associate in a Pak-US project.

🌍 Collaborations

Currently working with three international and several national collaborations.

📚 Publications

Title: Biallelic variants identified in 36 Pakistani families and trios with autism spectrum disorder
Authors: Hamid Khan, Ricardo Harripaul, Anna Mikhailov, Sumayah Herzi, …
Year: 2024

Title: Elucidating the clinical and genetic spectrum of inositol polyphosphate phosphatase INPP4A-related neurodevelopmental disorder
Authors: Lettie E Rawlins, Reza Maroofian, Stuart J Cannon, Muhannad Daana, Mina Zamani, Shamsul Ghani, …
Year: 2024

Title: Nigella sativa extract abrogates traumatic brain injury-induced memory impairment in adult mice
Authors: RU Khan, SM Jawad, MM Kiyani, SA Shah, S Bashir, Hamid Khan
Year: 2024

Title: Mutational spectrum associated with oculocutaneous albinism and Hermansky-Pudlak syndrome in nine Pakistani families
Authors: J Khan, S Asif, S Ghani, Hamid Khan, MW Arshad, SA Khan, S Lin, EL Baple, …
Year: 2024

Title: An Update on Recent Advancement in Autism Spectrum Disorder Treatment Strategies
Authors: Hamid Khan, M Uzair, H Riaz, B Khan, MI Shabbir
Year: 2023

Conclusion

Hamid Khan’s profile illustrates a strong commitment to advancing the field of biotechnology through research and education. His focus on the genetic underpinnings of rare disorders positions him as a valuable contributor to both academic and clinical settings. With a proven track record of research publications and collaborative projects, he is poised to make significant impacts in the realm of human genetics and molecular biology. His dedication to teaching and nurturing student curiosity further underscores his potential as an educator and mentor. As he seeks new opportunities, his combination of technical expertise, research experience, and passion for education will undoubtedly enable him to excel and inspire in any dynamic academic or research environment.